Table 4 The inhibitation diameters zone values (mm) for L1, L2, L3 and its complexes
From: Spectral, thermal, antimicrobial studies for silver(I) complexes of pyrazolone derivatives
Compounds | Microbial species | ||||||
|---|---|---|---|---|---|---|---|
Bacteria | Fungi | ||||||
E. coli | Coliform | S. aureus | Salmonella typhi | A.niger | P.expansum | ||
L1 | 10+1 ± 1.1 | 11+1 ± 1.8 | 12.5+1 ± 0.89 | 11.43+3 ± 0.79 | NA | 20+3 ± 1.3 | |
L1 / Ag(I) | 29.33+2 ± 1.58 | 18.65+2 ± 1.45 | 22.6+1 ± 1.88 | 21.6+3 ± 1.98 | NA | 16+3 ± 0.75 | |
L2 | 14.66+1 ± 1.1 | 15.13+1 ± 1.9 | 6.25+1 ± 0.81 | 7.8+1 ± 0.54 | NA | NA | |
L2 / Ag(I) | 29.6+2 ± 1.75 | 25.12+3 ± 1.33 | 9.5+1 ± 0.74 | 20+3 ± 2.1 | NA | NA | |
L3 | 11.2+1 ± 1.4 | 10.5+1 ± 0.95 | 13.6+1 ± 1.3 | 12.6+3 ± 0.78 | 14+2 ± 0.75 | NA | |
L3 / Ag(I) | 22.16+1 ± 2.4 | 15.32+1 ± 1.3 | 20.8+1 ± 2.2 | 22+3 ± 2.2 | 20+3 ± 2.6 | NA | |
AgNO3 |  | – | – | – | – | – | |
Control (DMF) | – | – | – | – | – | – | |
Standard | Nystain | – | – | – | – | 11 ± 1.1 | 00 |
Fluconazole | – | – | – | – | 00 | 00 | |
Amoxycillin/Clavulanic | 17 ± 1.1 | 14 ± 1.3 | 19 ± 1.8 | 00 | – | – | |
Cetaxime | 00 | 00 | 00 | 00 | – | – | |